We are an R&D company founded in Izmir in 2026 with the support of TÜBİTAK BiGG, developing lipid nanoparticle-based carrier systems for vaccines and gene therapy.

---

Deliver Biotech is an R&D company established as an entrepreneurial firm with the support of TÜBİTAK (The Scientific and Technological Research Council of Turkey) to develop innovative solutions in the fields of advanced biotechnology and drug delivery systems. Our company develops solutions for the needs of the pharmaceutical and biotechnology sectors by transforming scientific knowledge and technology into commercially viable products and services.

Deliver Biotech's core focus is the development of lipid nanoparticle (LNP) formulations for use in mRNA vaccines, gene therapies, and next-generation biological therapies, transforming them into innovative biotechnological drug solutions for use in various healthcare fields, particularly in gene therapies, cancer treatments, and personalized medicine applications.

In addition to our R&D activities, we provide scientific and technical consulting services for formulation development, preclinical studies, product development, and licensing processes. By combining our academic knowledge and over 35 years of scientific experience with industry needs, we contribute to the transformation of research ideas into innovative products and commercially viable technologies.

Deliver Biotech aims to develop next-generation formulation and delivery technologies by bringing together science, innovation, and entrepreneurship, and to transform these technologies into added value in the healthcare sector.